BladderBoneBrainBreastCervicalColonEsophagealKidneyLaryngealLeukemia CancerLiverLungLymphomaMouthOvarianPancreaticProstateRectalSkinTesticularThroatUterineHematology & OncologyUrologyBladder CancerBone CancerBrain CancerBreast CancerCervical CancerColon CancerEsophageal CancerKidney CancerLaryngeal CancerLeukemiaLiver CancerLung CancerLymphoma CancerMouth CancerOvarian CancerPancreatic CancerProstate CancerRectal CancerSkin CancerTesticular CancerThroat CancerCancerUterine Cancer
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
TUESDAY, April 2, 2019 (HealthDay News) -- Prostate cancer incidence and mortality rates are decreasing or stabilizing in most countries, according to a study presented at the annual meeting of the American Association for Cancer Research, held from March 29 to April 3 in Atlanta.
MaryBeth Freeman, M.P.H., and Ahmedin Jemal, D.V.M., Ph.D., from the American Cancer Society in Atlanta, and colleagues used the most recent cancer incidence data from the International Agency for Research on Cancer and mortality data from the World Health Organization to update prostate cancer incidence and mortality patterns across five continents.
During the most recent five years, the researchers found the highest incidence rates in Brazil, Lithuania, and Australia, while the lowest incidence rates were found in Asia (India, Thailand, and Bahrain). The Caribbean, sub-Saharan Africa, and parts of the former Soviet Union had the highest mortality rates, while the lowest rates were seen in Asia (Thailand and Turkmenistan). Of the 44 countries with high-quality incidence data, four countries had increases in prostate cancer incidence rates during the most recent five data years; decreases were seen in seven countries, and the remaining 33 countries had stable rates. Among the 71 countries considered for mortality trends, decreases in rates were seen in 14 countries and increases were seen in three countries, while the rates in 54 countries remained stable.
"By comparing rates from different countries, we can assess differences in detection practices and improvements in treatment," Freeman said in a statement.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 27, 2022
Read this Next
Other Trending Articles